文献速递心律失常

连续心律监测在阵发性房颤中检测到的缓慢与快速心律失常

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation.
PubMed 文献 · Heart · 2023-08-11

本研究为RACE V多中心观察性子研究,纳入392例阵发性房颤患者,使用植入式循环记录仪进行至少2年连续心律监测。结果显示45%患者出现严重缓慢心律失常或快速心室率房颤/房扑,无持续性室速发生;年龄>70岁、PR间期延长、CHA2DS2-VASc评分≥2与缓慢心律失常相关,而使用维拉帕米或地尔硫䓬与较低风险相关。

要点

  • 阵发性房颤患者中45%在连续监测中出现严重缓慢心律失常或快速心室率房颤/房扑。
  • 年龄>70岁、PR间期延长、CHA2DS2-VASc≥2与缓慢心律失常独立相关。
  • 使用维拉帕米或地尔硫䓬与缓慢心律失常风险降低相关(HR 0.4)。

核心结论

  • 在阵发性房颤患者中,近半数出现严重缓慢心律失常或快速心室率房颤/房扑,缓慢心律失常风险高于预期。

研究设计与样本

  • RACE V多中心观察性子研究,纳入392例阵发性自行终止房颤患者,均植入循环记录仪并连续监测至少2年。
  • 所有心率≥182次/分、≤30次/分或停搏≥5秒的心律事件由三名医生裁定。

主要发现

  • 共1272患者年监测中,175例(45%)患者发生1940次裁定事件。
  • 106例(27%)患者出现快速房颤或房扑,47例(12%)出现停搏≥5秒或心率≤30次/分,22例(6%)同时出现两类事件。
  • 未观察到持续性室性心动过速。

关键数值与推荐

  • 年龄>70岁与缓慢心律失常相关(HR 2.3,95%CI 1.4-3.9)。
  • PR间期延长与缓慢心律失常相关(HR 1.9,95%CI 1.1-3.1)。
  • CHA2DS2-VASc评分≥2与缓慢心律失常相关(HR 2.2,95%CI 1.1-4.5)。
  • 使用维拉帕米或地尔硫䓬与缓慢心律失常相关(HR 0.4,95%CI 0.2-1.0)。
  • 年龄>70岁与快速心律失常发生率较低相关。

临床怎么用

  • 对阵发性房颤患者,尤其高龄、PR间期延长或CHA2DS2-VASc≥2者,应关注缓慢心律失常风险。
  • 使用维拉帕米或地尔硫䓬时需权衡缓慢心律失常风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Atrial fibrillation (AF) is associated with adverse events including conduction disturbances, ventricular arrhythmias and sudden death. The aim of this study was to examine brady- and tachyarrhythmias using continuous rhythm monitoring in patients with paroxysmal self-terminating AF (PAF). METHODS: In this multicentre observational substudy to the Reappraisal of Atrial Fibrillation: interaction between hyperCoagulability, Electrical remodelling and Vascular destabilisation in the progression of AF (RACE V), we included 392 patients with PAF and at least 2 years of continuous rhythm monitoring. All patients received an implantable loop recorder, and all detected episodes of tachycardia ≥182 beats per minute (BPM), bradycardia ≤30 BPM or pauses ≥5 s were adjudicated by three physicians. RESULTS: Over 1272 patient-years of continuous rhythm monitoring, we adjudicated 1940 episodes in 175 patients (45%): 106 (27%) patients experienced rapid AF or atrial flutter (AFL), pauses ≥5 s or bradycardias ≤30 BPM occurred in 47 (12%) patients and in 22 (6%) patients, we observed both episode types. No sustained ventricular tachycardias occurred. In the multivariable analysis, age >70 years (HR 2.3, 95% CI 1.4 to 3.9), longer PR interval (HR 1.9, 1.1-3.1), CHA2DS2-VASc score ≥2 (HR 2.2, 1.1-4.5) and treatment with verapamil or diltiazem (HR 0.4, 0.2-1.0) were significantly associated with bradyarrhythmia episodes. Age >70 years was associated with lower rates of tachyarrhythmias. CONCLUSIONS: In a cohort exclusive to patients with PAF, almost half experienced severe bradyarrhythmias or AF/AFL with rapid ventricular rates. Our data highlight a higher than anticipated bradyarrhythmia risk in PAF. TRIAL REGISTRATION NUMBER: NCT02726698.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Frausing MHJP, Van De Lande ME, Maass AH, et al. Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation. Heart. 2023. PMID: 36948572. doi:10.1136/heartjnl-2022-322253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。